We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Robotic Guidance and Placement System Designed to Work inside MRI Bore

By MedImaging International staff writers
Posted on 14 Sep 2023
Print article
Image: The IGAR system is the world`s first FDA-cleared MRI-compatible robot (Photo courtesy of Insight Medbotics)
Image: The IGAR system is the world`s first FDA-cleared MRI-compatible robot (Photo courtesy of Insight Medbotics)

Innovations in imaging technology, robotics, and artificial intelligence are expanding the range of clinical applications and making MRI more user-friendly for both medical professionals and patients. However, MRI rooms remain among the most complex environments within a hospital due to the machine's powerful magnetic fields and the limited space available for medical staff. Now, a robotic guidance and placement system that can operate within an MRI bore could find various applications, including biopsies, treatment administration, and medical device placement.

The IGAR system from Insight Medbotics (Hamilton, ON, Canada) is the world's first and only robot FDA 510(k)-cleared for use inside an MRI. The clearance for the company's MRI-compatible robot applies to breast biopsy indications. IGAR is the first and only robotics system designed to work inside an MRI bore that has obtained this regulatory clearance. The IGAR technology platform has the potential to be adapted for future products that could transition seamlessly between various healthcare settings, from an MRI room to a traditional operating room or even a doctor's office.

Conceived by a unique team of world-leading experts in both surgical and robotic fields, IGAR's safety and effectiveness have been verified through peer-reviewed clinical research focused on breast biopsy. Beyond breast biopsy, the technology may also find use in targeting other organs and types of diseases, as well as in administering treatments and placing medical devices.

"Our team has long believed in the untapped potential of accessible MRI imaging, artificial intelligence and robotics together to improve quality of life for patients," said Fazila Seker, CEO of Insight Medbotics. "Many teams are researching viable paths to take robotics into the MRI suite, but IGAR is the first to secure FDA clearance. This regulatory achievement advances our long-term vision, and our commitment to delivering technology that supports the future of precision medicine."

Related Links:
Insight Medbotics 

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Compact C-Arm
Arcovis DRF-C S21
New
Ceiling-Mounted Digital Radiography System
Radiography 5000 C
Brachytherapy Planning System
Oncentra Brachy

Print article

Channels

Nuclear Medicine

view channel
Image: Researchers have identified a new imaging biomarker for tumor responses to ICB therapy (Photo courtesy of 123RF)

New PET Biomarker Predicts Success of Immune Checkpoint Blockade Therapy

Immunotherapies, such as immune checkpoint blockade (ICB), have shown promising clinical results in treating melanoma, non-small cell lung cancer, and other tumor types. However, the effectiveness of these... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.